Onco-Innovations Limited (CVE:ONCO) | Finanzwire

Basculer en Français

9475	Companies
185442	Keywords
117783	Articles
99298	Press releases

Headlines Articles Press releases Onco-Innovations Limited

Home
Companies
Onco-Innovations Limited

BRIEF

published on 01/30/2025 at 23:05, 10 months 5 days ago

Onco-Innovations' PNKP Inhibitors Display Potential in Cancer Therapy

Cancer Therapy Drug Resistance PNKP Inhibitors DNA Repair Chemo Enhancement
PRESS RELEASE

published on 01/30/2025 at 23:00, 10 months 5 days ago

Onco-Innovations' Licensed Technology Shows Promise in Enhancing Chemotherapy Effectiveness by Overcoming Cancer Cell Resistance and Inhibiting Cancer Cell Repair
Onco-Innovations announces breakthrough Technology enhancing cancer treatment efficacy by inhibiting DNA repair in cancer cells, potentially improving patient outcomes in a multi-billion-dollar market

Patient Outcomes Cancer Treatment Onco-Innovations DNA Repair Inhibitors Cancer Therapy Market
BRIEF

published on 01/29/2025 at 22:50, 10 months 6 days ago

Onco-Innovations' Private Placement Fully Subscribed

Private Placement Securities Market Confidence Onco-Innovations Fully Subscribed
PRESS RELEASE

published on 01/29/2025 at 22:45, 10 months 6 days ago

Onco-Innovations' Private Placement Fully Subscribed
Onco-Innovations Limited announces the full subscription of its non-brokered private placement, closing soon. Investors show strong confidence in the company's vision and mission in cancer research and treatment

Private Placement Investors Closing Date Cancer Research Onco-Innovations Limited
BRIEF

published on 01/24/2025 at 17:20, 10 months 11 days ago

Onco-Innovations Reports No Material Changes Amid Market Activity

Forward-looking Statements Cancer Research Market Activity Onco-Innovations Material Change
PRESS RELEASE

published on 01/24/2025 at 17:15, 10 months 11 days ago

Onco-Innovations Unaware of Any Material Change
Onco-Innovations Limited addresses recent market activity, confirming no material changes. The Canadian company focuses on cancer research and treatment with innovative therapies

Innovative Solutions Cancer Research Market Activity Canadian Company Onco-Innovations Limited
BRIEF

published on 01/23/2025 at 00:05, 10 months 13 days ago

Onco-Innovations Partners with Inka Health to Enhance Cancer Treatment

Oncology Drug Development AI In Healthcare Inka Health SynoGraph Technology
PRESS RELEASE

published on 01/23/2025 at 00:00, 10 months 13 days ago

Onco-Innovations Enters into LOI with Inka Health to Implement AI Technology Toward Cancer Detection and Drug Development
Onco-Innovations Limited announces letter of intent with Inka Health Corp. to acquire AI platform for precision oncology. Potential acquisition set to revolutionize drug development processes

Artificial Intelligence Precision Oncology Drug Development Onco-Innovations Limited Inka Health Corp.
BRIEF

published on 01/16/2025 at 23:05, 10 months 19 days ago

Onco-Innovations' Technology Shows Promise in Reducing Cancer Recurrence

Patient Outcomes Cancer Treatment Radiation Therapy PNKP Inhibitors DNA Repair
PRESS RELEASE

published on 01/16/2025 at 23:00, 10 months 19 days ago

Onco-Innovations' Licensed Technology Shown in Study to Successfully Prevent Regeneration of Cancer Cells
Onco-Innovations Limited announces breakthrough Technology targeting cancer cell regeneration and improving patient outcomes. The innovative PNKP inhibitors show potential to reduce cancer recurrence rates and enhance treatment effectiveness

Technology Patient Outcomes Cancer PNKP Inhibitors Onco-Innovations Limited

Accesswire

Published on 12/05/2025 at 02:35, 9 hours 29 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 9 hours 34 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 11 hours 4 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 12 hours 59 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 13 hours 4 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 11:14, 49 minutes ago

Halfords Group PLC: Director/PDMR Shareholding
Published on 12/05/2025 at 10:30, 1 hour 33 minutes ago

Tradegate Exchange and Börse Berlin merge to form Tradegate BSX
Published on 12/05/2025 at 10:15, 1 hour 48 minutes ago

Wuxi’s Liangxi District: Where 3,000 Years of Jiangnan Culture Thrives
Published on 12/05/2025 at 09:40, 2 hours 23 minutes ago

Chery Partners with 2025 Asian Youth Para Games, Taking Center Stage in Global Sports with Passion and Aspiration
Published on 12/05/2025 at 09:30, 2 hours 33 minutes ago

REPLOID Group AG: Exhibitor at the BIOGAS Convention & Trade Fair in Nuremberg, Germany

Les Echos

Published on 12/05/2025 at 08:45, 3 hours 19 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 18 hours 4 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 18 hours 19 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 18 hours 19 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day 5 hours ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health

View all LES ECHOS COMFI WIRE